LON:N4P - Ultima Stock Price, Price Target & More

GBX 20.25 +0.10 (+0.50 %)
(As of 04/20/2018 04:00 PM ET)
Previous CloseGBX 20.25
Today's RangeGBX 19.60 - GBX 20.50
52-Week RangeGBX 4.88 - GBX 35.70
Volume420,910 shs
Average Volume1.76 million shs
Market Capitalization£17.04 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Ultima (LON:N4P)

Ultima logoN4 Pharma Plc, a specialist pharmaceutical company, engages in the reformulation of existing drugs and vaccines to enhance their performance. The company reformulates commercialized generic drugs; and delivers novel and existing vaccines. Its products pipeline includes Sildenafil, a clinical stage product for the treatment of erectile dysfunction; Sartans, a clinical stage product for the treatment of hypertension; and Aprepitant, a clinical stage anti-emetic drug for oncology and pain relief, as well as Nuvac and Nuvec vaccines. The company's product also pipeline consists of Paroxetine, a clinical stage anti-depressant drug for the treatment of hot flashes and night sweats in menopausal women; and Duoloxetine, a clinical stage anti-depressant drug for the treatment of premature ejaculation. N4 Pharma Plc is based in Chellaston, the United Kingdom.

Receive N4P News and Ratings via Email

Sign-up to receive the latest news and ratings for N4P and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
SymbolLON:N4P
CUSIPN/A
Phone+44-1332-690061

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins1.05%
Return on Equity1.54%
Return on Assets1.46%

Miscellaneous

EmployeesN/A
Outstanding Shares74,710,000

How to Become a New Pot Stock Millionaire

Ultima (LON:N4P) Frequently Asked Questions

What is Ultima's stock symbol?

Ultima trades on the London Stock Exchange (LON) under the ticker symbol "N4P."

What price target have analysts set for N4P?

1 brokerages have issued 1-year price objectives for Ultima's stock. Their predictions range from GBX 12 to GBX 12. On average, they expect Ultima's share price to reach GBX 12 in the next year. View Analyst Ratings for Ultima.

Who are some of Ultima's key competitors?

Who are Ultima's key executives?

Ultima's management team includes the folowing people:
  • Mr. Nigel James Theobald, Chief Exec. Officer and Director (Age 54)
  • Mr. Paul Titley MRSC, C.Chem, Exec. Director
  • Mr. Andrew Leishman, Head of Nuvec® Devel.

Has Ultima been receiving favorable news coverage?

News coverage about N4P stock has been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Ultima earned a media sentiment score of 0.18 on Accern's scale. They also gave media coverage about the company an impact score of 46.79 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of Ultima?

Shares of N4P and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Ultima's stock price today?

One share of N4P stock can currently be purchased for approximately GBX 20.25.

How big of a company is Ultima?

Ultima has a market capitalization of £17.04 million.

How can I contact Ultima?

Ultima's mailing address is Weston House, 1 Bradgate Park View, DERBY, DE73 5UJ, United Kingdom. The company can be reached via phone at +44-1332-690061.


MarketBeat Community Rating for Ultima (N4P)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  45 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  102
MarketBeat's community ratings are surveys of what our community members think about Ultima and other stocks. Vote "Outperform" if you believe N4P will outperform the S&P 500 over the long term. Vote "Underperform" if you believe N4P will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Ultima (LON:N4P) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Ultima in the last 12 months. Their average twelve-month price target is GBX 12The high price target for N4P is GBX 12 and the low price target for N4P is GBX 12. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 12GBX 12GBX 12GBX 12

Ultima (LON:N4P) Consensus Price Target History

Price Target History for Ultima (LON:N4P)

Ultima (LON:N4P) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/5/2018Beaufort SecuritiesReiterated RatingSpeculative BuyView Rating Details
(Data available from 4/21/2016 forward)

Earnings

Dividends

Ultima (LON:N4P) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Ultima (LON N4P) Insider Trading and Institutional Ownership History

Insider Trading History for Ultima (LON:N4P)

Ultima (LON N4P) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/10/2017Nigel TheobaldInsiderBuy56,656GBX 8£4,532.48
(Data available from 1/1/2013 forward)

Headlines

Ultima (LON N4P) News Headlines

Source:
DateHeadline
WISeKey Cybersecurity Technology secures TraNexus Blockchain based Travel EngineWISeKey Cybersecurity Technology secures TraNexus Blockchain based Travel Engine
feeds.benzinga.com - April 18 at 1:48 AM
Ground-breaking international conference Resources for Future Generations (#RFG2018) to be held in Vancouver, BCGround-breaking international conference 'Resources for Future Generations' (#RFG2018) to be held in Vancouver, BC
feeds.benzinga.com - April 17 at 11:52 AM
Beaufort Securities Reiterates Speculative Buy Rating for N4 Pharma (N4P)Beaufort Securities Reiterates Speculative Buy Rating for N4 Pharma (N4P)
www.americanbankingnews.com - April 15 at 6:44 PM
Beaufort Securities Reaffirms Speculative Buy Rating for N4 Pharma (N4P)Beaufort Securities Reaffirms Speculative Buy Rating for N4 Pharma (N4P)
www.americanbankingnews.com - April 8 at 6:28 PM
N4 Pharma (N4P) Given Speculative Buy Rating at Beaufort SecuritiesN4 Pharma (N4P) Given Speculative Buy Rating at Beaufort Securities
www.americanbankingnews.com - April 7 at 1:43 PM
N4 Pharmas (N4P) "Speculative Buy" Rating Reiterated at Beaufort SecuritiesN4 Pharma's (N4P) "Speculative Buy" Rating Reiterated at Beaufort Securities
www.americanbankingnews.com - April 1 at 12:24 PM
N4 Pharma (N4P) Receives "Speculative Buy" Rating from Beaufort SecuritiesN4 Pharma (N4P) Receives "Speculative Buy" Rating from Beaufort Securities
www.americanbankingnews.com - March 25 at 4:18 PM
N4 Pharma Raises Nets GBP159,700 From Warrant Exercise (ALLISS)N4 Pharma Raises Nets GBP159,700 From Warrant Exercise (ALLISS)
www.morningstar.co.uk - March 9 at 3:22 PM
Who Are The Major Shareholders In N4 Pharma Plc (LON:N4P)?Who Are The Major Shareholders In N4 Pharma Plc (LON:N4P)?
finance.yahoo.com - March 1 at 3:20 PM
N4 Pharma Issues 135,714 Shares Following Warrants Exercise (ALLISS)N4 Pharma Issues 135,714 Shares Following Warrants Exercise (ALLISS)
www.morningstar.co.uk - February 22 at 3:19 PM
N4 Pharma To Issue 150,000 Shares Following Warrants Exercise (ALLISS)N4 Pharma To Issue 150,000 Shares Following Warrants Exercise (ALLISS)
www.morningstar.co.uk - February 19 at 3:16 PM
N4 Pharma Raises Further GBP33,500 After Warrant Exercise (ALLISS)N4 Pharma Raises Further GBP33,500 After Warrant Exercise (ALLISS)
www.morningstar.co.uk - February 14 at 3:46 PM
DIRECTOR DEALINGS: N4 Pharma Says CEO Owns 19.7% Stake (ALLISS)DIRECTOR DEALINGS: N4 Pharma Says CEO Owns 19.7% Stake (ALLISS)
www.morningstar.co.uk - February 9 at 8:00 AM
Award of Grant and Collaboration with MedImmune UK - London South East (blog)Award of Grant and Collaboration with MedImmune UK - London South East (blog)
www.lse.co.uk - February 4 at 6:03 PM
N4 Pharma Says It Will Net GBP30,357 From Warrants Exercise (ALLISS)N4 Pharma Says It Will Net GBP30,357 From Warrants Exercise (ALLISS)
www.morningstar.co.uk - February 3 at 5:44 PM
N4 Pharma Raises GBP33,500 After Warrant Exercise (ALLISS)N4 Pharma Raises GBP33,500 After Warrant Exercise (ALLISS)
www.morningstar.co.uk - January 31 at 10:41 AM
What Kind Of Risk And Return Should You Expect For N4 Pharma Plc (AIM:N4P)?What Kind Of Risk And Return Should You Expect For N4 Pharma Plc (AIM:N4P)?
finance.yahoo.com - January 31 at 10:41 AM
Beaufort Securities Reiterates "Speculative Buy" Rating for N4 Pharma (N4P)Beaufort Securities Reiterates "Speculative Buy" Rating for N4 Pharma (N4P)
www.americanbankingnews.com - November 30 at 11:02 PM
N4 Pharma Plc (N4P) Insider Buys £4,532.48 in StockN4 Pharma Plc (N4P) Insider Buys £4,532.48 in Stock
www.americanbankingnews.com - November 10 at 12:38 PM
N4 Pharma PLC (N4P) Posts  Earnings ResultsN4 Pharma PLC (N4P) Posts Earnings Results
www.americanbankingnews.com - September 25 at 7:22 AM
N4 Pharma PLC (N4P) Rating Reiterated by Beaufort SecuritiesN4 Pharma PLC (N4P) Rating Reiterated by Beaufort Securities
www.americanbankingnews.com - July 3 at 6:34 AM

SEC Filings

Ultima (LON:N4P) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Ultima (LON N4P) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.